Child sex ratio (CSR) in India has declined from 927 in 2001 to 918 in 2011 (girls per 1,000 boys), according to a new report entitled Missing Girls: Mapping the Adverse Child Sex Ratio in India (Census 2011). Of the total 640 districts in the country, 429 districts have experienced decline in CSR (see the link below).   Of these 429 districts, 26 districts exhibited drastic decline (of 50 points or more),...

-Livemint The development economist on the Modi government's initiatives and his stand on them, and MGNREGS The Narendra Modi-led government should consider replacing inefficient subsidies with a basic monthly income for all citizens, says Pranab Bardhan , emeritus professor of economics at the University of California at Berkeley. Bardhan, who recently sparred with economists Jagdish Bhagwati and Arvind Panagariya in a debate over the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS),...

-The Times of India NEW DELHI: The parliamentary estimates committee headed by BJP MP Murli Manohar Joshi, in its first report tabled on Thursday, on arsenic in ground water, has criticized the Centre for "neglecting" the serious issue that impacts at least 7 crore people across six states, according to CSIR estimates (data from different ministries and departments on the subject varies widely, the committee found). The panel has recommended that the...

-The Hindu It is not the responsibility of the government alone to act in order to curb corruption; corporate firms need to be proactive as well in checking fraudulent financial practices The winter session of Parliament witnessed a noisy debate on the black money controversy. Governments of all hues have disappointed the Indian janata on the issue of black money and the failure is often associated with a perceived nexus between politicians...

-The Telegraph Regulators in several European countries are suspending marketing approval for 25 generic drugs because of concerns over the quality of data from human studies conducted by an Indian contract research company, a French medical safety agency said on Friday. Drug regulators in Belgium, France, Germany and Luxembourg have decided to suspend the marketing authorisation for the generic drugs after they discovered "irregularities" in documents relating to human studies conducted by...